# 0143-9930-10 · Cefotaxime Sodium Powder, for Solution · Hikma Pharmaceuticals USA, Inc. — FDA drug shortage duration tracker

For 0143-9930-10 · Cefotaxime Sodium Powder, for Solution · Hikma Pharmaceuticals USA, Inc., package ndc is 0143-9930-10; generic name is Cefotaxime Sodium Powder, for Solution; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.

- **Package NDC:** 0143-9930-10 _(verified: appears in the quote below)_
- **Generic name:** Cefotaxime Sodium Powder, for Solution _(verified: appears in the quote below)_
- **Manufacturer:** Hikma Pharmaceuticals USA, Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Estimated recovery: TBD _(verified: appears in the quote below)_
- **Initial posting date:** 02/17/2015 _(verified: appears in the quote below)_
- **Last update date:** 08/13/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 4214 _(our reading, not quoted from the source)_
- **Reason for shortage:** Demand increase for the drug _(verified: appears in its own passage below)_
- **Dosage form:** Powder, For Solution _(verified: appears in its own passage below)_
- **Therapeutic category:** Anti-Infective _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "02/17/2015", "package_ndc": "0143-9930-10", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/13/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Status

> "update_date": "08/13/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Last update date

> "update_date": "08/13/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Reason for shortage

> "update_date": "08/13/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Dosage form

> "update_date": "08/13/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

### Therapeutic category

> "update_date": "08/13/2026", "therapeutic_category": [ "Anti-Infective", "Pediatric" ], "dosage_form": "Powder, For Solution", "presentation": "Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-10. Review by: 2026-09-13.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).